As the abortion pill mifepristone faces an unclear future in some states, researchers have identified a drug with a similar chemical profile that could serve as an effective alternative. 

In less than a year, Mark Cuban's Cost Plus Marketplace has expanded its portfolio to more than 6,000 medicines. 

Becker's asked pharmacy executives from hospitals and health systems across the U.S. to share the most significant change they're making this year.

Ruth Cassidy, PharmD, recently joined New York City-based Montefiore Health System as the system's inaugural chief pharmacy officer. With years of experience in hospital and community pharmacy practice, Dr. Cassidy is focused on optimizing pharmacy operations, improving patient care and…

The FDA has added a boxed warning, its most serious designation, to Copaxone and Glatopa due to the risk of anaphylaxis, a rare but serious allergic reaction. 

A recent study conducted by researchers from Seattle-based University of Washington  and Durham, N.C.-based Duke University found a strong association between the use of fall-risk increasing drugs and a higher incidence of injurious falls in patients with chronic obstructive pulmonary…

In 2025, the three largest pharmacy benefit managers are largely rejecting biosimilars from their formularies, with the exception of their own private-label medicines, Drug Channels reported Jan. 22. 

Johnson & Johnson has received FDA approval for Spravato nasal spray as the first and only monotherapy for adults with treatment-resistant depression. 

The FDA issued a warning letter to Sanofi regarding significant manufacturing violations at its Genzyme Corporation Facility in Framingham, Mass. 

Norwich, Conn.-based Backus Hospital, part of Hartford (Conn.) Healthcare, celebrated the grand opening of its new retail pharmacy with a ribbon-cutting ceremony Jan. 21.